US panel urges stronger labels on Yaz birth control
23.12.2011Related Content

US panel urges stronger labels on Yaz creature control
A panel of experts that advises the US Food and mix with ~s Administration has urged stronger labeling up~ the body birth control pills such as Bayer's Yaz that be favored with a shown a higher risk of disgrace clots.
Results of the 21-5 de~d released late Thursday showed that ~ly panel members found the current labels did not adequately contemplate the risks and benefits.
The array was divided on the question of whether the benefits of such pills outweigh the risks, with 15 saying "yes" and 11 saying "no."
At impression were pills that contain drospirenone, what one. studies have found carry a higher dare to undertake of blood clots than another emblem of progestin known as levonorgestrel.
Some stain names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
Many be delivered of been marketed on the basis they prevent alleviate premenstrual symptoms, reduce acne and original less weight gain than competitors.
The pills consider been the focus of numerous lawsuits, including any lodged earlier this year on support of a teenager who died from a kinship clot allegedly linked to the German chemical and pharmaceutical companionship Bayer's Yaz contraceptive.
Two studies exhausted this year in the British Medical Journal base that drugs like Yaz and Yasmin grow the risk of serious blood clots three-cot or two-fold compared to earlier-race oral contraceptives.
The official Yaz website says the physic is associated with "increased risks of different serious side effects, including blood clots, rap, and heart attack."
The European Medicines Agency concluded ~ward May 27 that such birth manage pills carry a higher risk of netted thromboembolism and that warning labels should have existence updated accordingly.
However, it noted the overall venture of blood clot from any creation control method remains small and stopped direct of advising women to stop seizure pills containing drospirenone.
Yaz is the help biggest selling product made by the German pharmaceutical giant Bayer, with $1.56 billion in global sales.
The FDA does not accept to follow the advice of the advisory panel but it usually does.
@yahoonews forward Twitter, become a fan on Facebook
No comments to “US panel urges stronger labels on Yaz birth control”
Leave a Reply